Literature DB >> 6609306

Preparation of T-lymphocyte lines and clones with specificities to preselected protein sites by in vitro passage with free synthetic peptides: demonstration with myoglobin sites.

M Yoshioka, G S Bixler, M Z Atassi.   

Abstract

Recently, this laboratory has demonstrated that antibodies to preselected regions of a protein can be obtained by immunization with free small synthetic peptides (6-7 residues) without conjugation to a carrier. In the present work, we report the use of free synthetic peptides representing myoglobin (Mb) antigenic sites to prepare T-cell lines and clones of preselected specificities. Lymph node cells from mice primed in vivo with sperm-whale Mb were periodically passaged in vitro with synthetic peptide. After several passages, the peptide-driven long term T-cell cultures responded to the intact protein and exclusively to the peptide that was used to drive the cells. From these cultures, T-cell clones were prepared that responded only to the driving peptide and to the whole protein. The ability to prepare T-cell lines and T-cell clones with preselected submolecular specificities to a protein by driving cultures with desired synthetic peptides affords an important and simple tool for basic immunological investigations and for clinical applications.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6609306     DOI: 10.1016/0161-5890(83)90123-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  13 in total

1.  Profile of the continuous antigenic regions on the extracellular part of the alpha chain of an acetylcholine receptor.

Authors:  B Mulac-Jericević; J Kurisaki; M Z Atassi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

2.  T cells specific for alpha-beta interface regions of hemoglobin recognize the isolated subunit but not the tetramer and indicate presentation without processing.

Authors:  M Z Atassi; M Yoshioka; G S Bixler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Conformation-dependent recognition of a protein by T cells requires presentation without processing.

Authors:  M Z Atassi; G S Bixler; T Yokoi
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

4.  T-cell recognition and antigen presentation of myoglobin. Protein recognition by site-specific T-cell clones is influenced by amino acid substitutions outside the site.

Authors:  M Yoshioka; M Z Atassi
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

5.  Profile of the alpha-bungarotoxin-binding regions on the extracellular part of the alpha-chain of Torpedo californica acetylcholine receptor.

Authors:  B Mulac-Jericevic; M Z Atassi
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

6.  Non-specific peptide size effects in the recognition by site-specific T-cell clones. Demonstration with a T site of myoglobin.

Authors:  M Z Atassi; M Yoshioka; M Bean; G S Bixler
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

7.  Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D.

Authors:  E C DeFreitas; B Dietzschold; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Antigen presentation of lysozyme: T-cell recognition of peptide and intact protein after priming with synthetic overlapping peptides comprising the entire protein chain.

Authors:  G S Bixler; T Yoshida; M Z Atassi
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

9.  T-cell recognition of human haemoglobin. Localization of the full T-cell recognition profile of the beta-chain by a comprehensive synthetic strategy.

Authors:  M Yoshioka; N Yoshioka; M Z Atassi
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

10.  The murine bm12 gene conversion provides evidence that T cells recognize predominantly Ia conformation.

Authors:  H Y Tse; S Kanamori; W D Walsh; T H Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.